ZTlido
Commercial- Indications
- Post-herpetic neuralgia
Company intelligence / Profile preview
Scilex Pharmaceuticals
Palo Alto, California, USAscilexholding.com ↗
- Ownership
- Public · SCLX
- Development stage
- Commercial
01
Overview
Scilex has three FDA-approved non-opioid products on the market and several late-stage pipeline candidates. ZTlido® shows strong sales growth and international distribution deals. SP‑102 met primary and secondary endpoints in pivotal phase 3 trial. SP‑103 completed phase II with clear path to NDA after phase III; projected blockbuster potential. SP‑104 completed multiple phase I trials.
- Therapeutic areas
- NeurologyRheumatology
- Modalities
- Small moleculeBiologicDevice (topical patch)Viscous gel formulation
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Joint venture “Scilex Bio” formed with IPMC/Bio Innovation Consortium to develop KDS2010 (MAO-B inhibitor) for obesity/neurodegenerative diseases including Alzheimer’s disease
Beyond the preview
Go deeper on Scilex Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scilex Pharmaceuticals.